lithium carbonate + lamotrigine

Lithium carbonate + lamotrigine is a combination of two small molecule mood stabilizers used primarily in the management of bipolar disorder, especially in patients who are treatment-resistant or have not responded adequately to monotherapy. Lithium carbonate acts mainly by modulating neurotransmitter release and second messenger systems, stabilizing mood and reducing the risk of manic episodes. Lamotrigine is an anticonvulsant that inhibits voltage-sensitive sodium channels, suppressing glutamate release and providing antidepressant effects. The combination leverages the strengths of both agents—lithium's efficacy in preventing mania and suicide, with lamotrigine's effectiveness against bipolar depression—offering a broader spectrum of mood stabilization than either drug alone[1][2][4][5][8]. This regimen is typically reserved for cases where monotherapy has failed or when both manic and depressive symptoms need to be addressed simultaneously.

Other names

lithium + lamotriginelithium carbonate and lamotrigine